Jefferies Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$9.37M Buy
50,976
+23,958
+89% +$4.77M 0.08% 200
2022
Q2
$4.54M Buy
27,018
+26,070
+2,750% +$5.6M 0.04% 380
2022
Q1
$238K Sell
948
-72,781
-99% -$18.3M ﹤0.01% 1231
2021
Q4
$18.9M Buy
73,729
+9,279
+14% +$2.27M 0.11% 145
2021
Q3
$15.6M Sell
64,450
-44,227
-41% -$10.8M 0.11% 167
2021
Q2
$22.5M Buy
108,677
+40,994
+61% +$8.36M 0.14% 112
2021
Q1
$12.7M Buy
67,683
+28,878
+74% +$5.09M 0.11% 148
2020
Q4
$6.38M Buy
38,805
+21,920
+130% +$3.21M 0.05% 330
2020
Q3
$2.1M Sell
16,885
-18,473
-52% -$2.29M 0.02% 549
2020
Q2
$3.43K Buy
35,358
+21,694
+159% +$2.26M 0.04% 373
2020
Q1
$1.23M Buy
13,664
+13,577
+15,606% +$1.76M 0.01% 923
2019
Q4
$13K Sell
87
-51,280
-100% -$6.89M ﹤0.01% 2489
2019
Q3
$6.19M Buy
51,367
+51,284
+61,788% +$6.63M 0.05% 409
2019
Q2
$11K Sell
83
-43,203
-100% -$5.46M ﹤0.01% 2443
2019
Q1
$5.64M Buy
43,286
+11,461
+36% +$1.54M 0.05% 392
2018
Q4
$3.96M Buy
31,825
+26,062
+452% +$3.5M 0.03% 512
2018
Q3
$802K Sell
5,763
-21,986
-79% -$2.74M 0.01% 1437
2018
Q2
$2.85M Sell
27,749
-50,488
-65% -$5.11M 0.02% 717
2018
Q1
$7.59M Buy
78,237
+77,737
+15,547% +$7.54M 0.04% 330
2017
Q4
$44K Sell
500
-62,288
-99% -$5M ﹤0.01% 2388
2017
Q3
$5M Sell
62,788
-11,666
-16% -$938K 0.03% 536
2017
Q2
$6.49M Buy
74,454
+72,747
+4,262% +$6.15M 0.04% 418
2017
Q1
$152K Sell
1,707
-5,423
-76% -$452K ﹤0.01% 2084
2016
Q4
$528K Sell
7,130
-12,878
-64% -$964K ﹤0.01% 1557
2016
Q3
$1.51M Buy
20,008
+1,848
+10% +$142K 0.01% 1067
2016
Q2
$1.4M Buy
18,160
+14,842
+447% +$1.17M 0.01% 1022
2016
Q1
$259K Sell
3,318
-87,091
-96% -$6.08M ﹤0.01% 1742
2015
Q4
$6.11M Sell
90,409
-37,641
-29% -$2.63M 0.03% 380
2015
Q3
$9.91M Sell
128,050
-259,830
-67% -$23M 0.06% 268
2015
Q2
$35.2M Buy
387,880
+386,728
+33,570% +$31M 0.18% 89
2015
Q1
$87K Sell
1,152
-2,619
-69% -$188K ﹤0.01% 1882
2014
Q4
$277K Sell
3,771
-6,295
-63% -$442K ﹤0.01% 1580
2014
Q3
$710K Buy
10,066
+1,288
+15% +$85.1K ﹤0.01% 1166
2014
Q2
$495K Sell
8,778
-326,981
-97% -$17.3M ﹤0.01% 1244
2014
Q1
$17.6M Buy
335,759
+101,257
+43% +$5.04M 0.17% 109
2013
Q4
$11.2M Buy
234,502
+219,267
+1,439% +$10.1M 0.07% 150
2013
Q3
$651K Sell
15,235
-16,089
-51% -$629K 0.01% 1095
2013
Q2
$1.13M Buy
+31,324
New +$1.21M 0.01% 716

Other funds holding HCA

Jefferies Group's HCA Position: Q3 2022 in Review

Jefferies Group increased its HCA Healthcare (HCA) stake by 89% in Q3 2022, buying an estimated $4.77M and bringing the position to 50,976 shares worth $9.37M. The position accounts for 0.08% of the portfolio, ranked #200.

Jefferies Group first reported a position in HCA in Q2 2013 and has held it in 38 quarters since. The position peaked at $35.2M in Q2 2015. 867 funds tracked by Wall St. Rank hold HCA as of Q3 2022.

  • Jefferies Group held 50,976 shares of HCA Healthcare worth $9.37M as of Q3 2022.
  • Jefferies Group bought 23,958 HCA Healthcare shares in Q3 2022, an estimated $4.77M.
  • HCA Healthcare made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #200 holding.
  • Jefferies Group first reported a position in HCA Healthcare in Q2 2013 and has held it in 38 quarters since.
  • Jefferies Group's HCA Healthcare position peaked at $35.2M in Q2 2015.
  • 867 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.